Patients with inflammatory bowel disease (IBD) require long-term pharmacotherapy. Due to the wide variety of clinically available drugs, medication safety has become increasingly concerning. As an indispensable component of pharmaceutical formulations, drug excipients may induce various adverse reactions, including rash, allergic responses, and gastrointestinal discomfort, and may even lead to severe organic injury. However, they are often overlooked in clinical practice. Therefore, identifying and managing excipient-related adverse reactions is crucial for ensuring medication safety. To address this issue, this article systematically reviews common excipients in IBD therapeutics, the underlying mechanisms of excipient-induced adverse reactions, and corresponding management strategies, aiming to enhance clinicians' awareness of excipient-related issues, improve their ability to recognize and manage such reactions, and ultimately ensure patient safety.

To analyze potential adverse drug events(ADEs) associated with ustekinumab and upadacitinib in the treatment of inflammatory bowel disease(IBD) based on an international authoritative database, thereby providing evidence for clinical medication safety.

Bipolar disorder is a chronic mental disorder with a high rate of relapse, disability and suicide. Safe, effective and rapid onset non-invasive neuromodulation therapy technology is becoming a research hotspot in the treatment of bipolar disorder. In this paper, the latest clinical research progress of the main techniques in this field is summarized and reviewed, and its future prospects is also forecasted.

Repetitive transcranial magnetic stimulation (rTMS) has become an essential method in psychiatric disorders. However, many problems occurred in clinical application. This article interpreted the Association Standard T/CMEAS 011-2023'Operating Specifications for Repetitive Transcranial Magnetic Stimulation in Clinical Applications on Psychiatric Disorders′ released by the Chinese Medicine Education Association. The main content included a range of applications, normative references, terms and definitions, site specifications, equipment specifications, ability specifications of rTMS operators and rTMS process specifications.This article provided suggestions for clinical applications of rTMS on psychiatric disorders.

Repetitive transcranial magnetic stimulation (rTMS) has become an essential method in psychiatric disorders. However, many problems occurred in clinical application. This article interpreted the Association Standard T/CMEAS 011-2023'Operating Specifications for Repetitive Transcranial Magnetic Stimulation in Clinical Applications on Psychiatric Disorders′ released by the Chinese Medicine Education Association. The main content included a range of applications, normative references, terms and definitions, site specifications, equipment specifications, ability specifications of rTMS operators and rTMS process specifications.This article provided suggestions for clinical applications of rTMS on psychiatric disorders.

Bipolar disorder is a chronic mental disorder with a high rate of relapse, disability and suicide. Safe, effective and rapid onset non-invasive neuromodulation therapy technology is becoming a research hotspot in the treatment of bipolar disorder. In this paper, the latest clinical research progress of the main techniques in this field is summarized and reviewed, and its future prospects is also forecasted.

Occupational contact dermatitis (OCD) is an occupational inflammatory skin disease. According to its pathogenesis, it can be divided into irritant contact dermatitis and allergic contact dermatitis. This review introduced the high-risk occupations of OCD, its incidence, common irritants and allergens, and corresponding treatments. Agriculture workers, construction workers, production workers, hairdressers, and medical workers are high-risk occupations of OCD who should be paid attention to.

Objective To investigate the association of transforming growth factor (TGF) gene rs1800469 (TGF1-509C/T) and rs1982073 (TGF1+869T/C) single nucleotide polymorphisms (SNP) with susceptibility of lung cancer. Methods The case group consisted of 193 histologically diagnosed lung cancer patients, and control group of 211 controls were selected from cancer-free patients at the same time. The single nucleotide polymorphisms of rs1800469 (TGF1-509C/T) and rs1982073(TGF1+869T/C) were analyzed by real-time fluorescent quantitative reverse transcription polymerase chain reaction method. The demographic characteristics, correlated risk factors of exposure and SNP between 2 groups were compared. Results The genotype distribution frequency of TGF1+869T/C and TGF1-509C/T in control group was accorded with Hardy-Weinberg law (P>0.05). The TT, TC and CC genotype distribution frequency in TGF1+869T/C in case group were 16.1%(31/193), 55.4%(107/193) and 28.5%(55/193), while these in control group were 22.3% (47/211), 50.2% (106/211) and 27.5% (58/211), and there were no statistical differences (P>0.05). The TT, TC and CC genotype distribution frequency in TGF1-509C/T in case group were 28.0%(54/193), 56.0%(108/193) and 16.1%(31/193), while these in control group were 27.0% (57/211), 51.2% (108/211) and 21.8% (46/211), and there were no statistical differences (P>0.05). The allele in rs1800469 (TGF1-509C/T) and rs1982073 (TGF1+869T/C) showed no association with lung cancer (P>0.05). Conclusions TGF gene SNP may not be associated with susceptibility to lung cancer in Han Chinese in North China.